Our website is made possible by displaying online advertisements to our visitors.
Please consider supporting us by disabling your ad blocker.

PHARMA

Quarterly rpt on consolidated results for the financial period ended 31/3/2007

PHARMANIAGA BERHAD

Financial Year End

31/12/2007
Quarter1
Quarterly report for the financial period ended31/03/2007
The figureshave not been audited

SUMMARY OF KEY FINANCIAL INFORMATION
31/03/2007

 
INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR
CORRESPONDING
QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR
CORRESPONDING
PERIOD
31/03/2007
31/03/2006
31/03/2007
31/03/2006
RM'000
RM'000
RM'000
RM'000
1Revenue
256,235
250,754
256,235
250,754
2Profit/(loss) before tax
10,230
8,911
10,230
8,911
3Profit/(loss) for the period
6,493
5,916
6,493
5,916
4Profit/(loss) attributable to ordinary equity holders of the parent
6,069
5,459
6,069
5,459
5Basic earnings/(loss) per share (sen)
5.67
5.10
5.67
5.10
6Proposed/Declared dividend per share (sen)
0.00
0.00
0.00
0.00
 
AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR END
7
Net assets per share attributable to ordinary equity holders of the parent (RM)
3.0000
2.9600

Note: For full text of the above announcement, please access KLSE Web site at www.klse.com.my


Remarks :
No interim ordinary dividend has been declared for the financial period ended 31 March 2007 (2006:nil).


Announcement Info

Company NamePHARMANIAGA BERHAD  
Stock Name PHARMA    
Date Announced25 May 2007  
CategoryFinancial Results
Reference NoPB-070525-63659